In CF, where A1AT levels and activity are impaired for a variety of reasons, as discussed, an inhibition approach focusing on miRNAs that regulate the 3’UTR of the SERPINA1 mRNA would appear to be worth considering. Here, SERPINA1 is linked to cystic fibrosis.